| sodium phenylbutyrate / Generic mfg. |
NCT00212316: Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) |
|
|
| Completed | 2 | 60 | US | sodium phenylbutyrate | University of Rochester, HP Therapeutics Foundation, Massachusetts General Hospital, Columbia University, University of Iowa, University of California, San Diego, University of Kansas, University of Alabama at Birmingham, Johns Hopkins University | Huntington's Disease | | 06/06 | | |
NCT00551200: Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders |
|
|
| Completed | 2 | 14 | US | HPN-100, BUPHENYL®, Sodium Phenylbutyrate, NaPBA | Horizon Pharma Ireland, Ltd., Dublin Ireland | Urea Cycle Disorders | 07/08 | 12/08 | | |
NCT01096095: Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 |
|
|
| Withdrawn | 2 | 0 | RoW | Placebo, Sodium Phenylbutyrate | Hospital de Clinicas de Porto Alegre, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil | Spinocerebellar Ataxia Type 3 | 12/10 | 07/11 | | |
NCT00345605: Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder |
|
|
| Completed | 2 | 12 | US | Sodium Phenylbutyrate, Buphenyl-TM, Arginine | Brendan Lee, Office of Rare Diseases (ORD), Rare Diseases Clinical Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Argininosuccinic Aciduria, Amino Acid Metabolism, Inborn Errors, Urea Cycle Disorders | 05/11 | 11/12 | | |
NCT00947544: Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders |
|
|
| Completed | 2 | 17 | US, Canada | HPN-100, GT4P, Glyceryl tri-(4-phenylbutyrate), NaPBA | Horizon Pharma Ireland, Ltd., Dublin Ireland | Urea Cycle Disorders | 08/11 | 08/11 | | |
